This report contains market size and forecasts of Vaccine Conjugate in global, including the following market information:
Global Vaccine Conjugate Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Vaccine Conjugate Market Sales, 2016-2021, 2022-2027, (K Doses)
Global top five Vaccine Conjugate companies in 2020 (%)
The global Vaccine Conjugate market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine Conjugate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine Conjugate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Vaccine Conjugate Market Segment Percentages, By Type, 2020 (%)
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Vaccine Conjugate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Vaccine Conjugate Market Segment Percentages, By Application, 2020 (%)
Children
Adult
Global Vaccine Conjugate Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses)
Global Vaccine Conjugate Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccine Conjugate revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Vaccine Conjugate revenues share in global market, 2020 (%)
Key companies Vaccine Conjugate sales in global market, 2016-2021 (Estimated), (K Doses)
Key companies Vaccine Conjugate sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Vaccine Conjugate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Conjugate Overall Market Size
2.1 Global Vaccine Conjugate Market Size: 2021 VS 2027
2.2 Global Vaccine Conjugate Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Vaccine Conjugate Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Vaccine Conjugate Players in Global Market
3.2 Top Global Vaccine Conjugate Companies Ranked by Revenue
3.3 Global Vaccine Conjugate Revenue by Companies
3.4 Global Vaccine Conjugate Sales by Companies
3.5 Global Vaccine Conjugate Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Vaccine Conjugate Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Vaccine Conjugate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine Conjugate Players in Global Market
3.8.1 List of Global Tier 1 Vaccine Conjugate Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccine Conjugate Market Size Markets, 2021 & 2027
4.1.2 Hib Vaccine
4.1.3 Meningococcal Vaccine
4.1.4 Pneumococcal Vaccine
4.1.5 Others
4.2 By Type - Global Vaccine Conjugate Revenue & Forecasts
4.2.1 By Type - Global Vaccine Conjugate Revenue, 2016-2021
4.2.2 By Type - Global Vaccine Conjugate Revenue, 2022-2027
4.2.3 By Type - Global Vaccine Conjugate Revenue Market Share, 2016-2027
4.3 By Type - Global Vaccine Conjugate Sales & Forecasts
4.3.1 By Type - Global Vaccine Conjugate Sales, 2016-2021
4.3.2 By Type - Global Vaccine Conjugate Sales, 2022-2027
4.3.3 By Type - Global Vaccine Conjugate Sales Market Share, 2016-2027
4.4 By Type - Global Vaccine Conjugate Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccine Conjugate Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Vaccine Conjugate Revenue & Forecasts
5.2.1 By Application - Global Vaccine Conjugate Revenue, 2016-2021
5.2.2 By Application - Global Vaccine Conjugate Revenue, 2022-2027
5.2.3 By Application - Global Vaccine Conjugate Revenue Market Share, 2016-2027
5.3 By Application - Global Vaccine Conjugate Sales & Forecasts
5.3.1 By Application - Global Vaccine Conjugate Sales, 2016-2021
5.3.2 By Application - Global Vaccine Conjugate Sales, 2022-2027
5.3.3 By Application - Global Vaccine Conjugate Sales Market Share, 2016-2027
5.4 By Application - Global Vaccine Conjugate Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Vaccine Conjugate Market Size, 2021 & 2027
6.2 By Region - Global Vaccine Conjugate Revenue & Forecasts
6.2.1 By Region - Global Vaccine Conjugate Revenue, 2016-2021
6.2.2 By Region - Global Vaccine Conjugate Revenue, 2022-2027
6.2.3 By Region - Global Vaccine Conjugate Revenue Market Share, 2016-2027
6.3 By Region - Global Vaccine Conjugate Sales & Forecasts
6.3.1 By Region - Global Vaccine Conjugate Sales, 2016-2021
6.3.2 By Region - Global Vaccine Conjugate Sales, 2022-2027
6.3.3 By Region - Global Vaccine Conjugate Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Vaccine Conjugate Revenue, 2016-2027
6.4.2 By Country - North America Vaccine Conjugate Sales, 2016-2027
6.4.3 US Vaccine Conjugate Market Size, 2016-2027
6.4.4 Canada Vaccine Conjugate Market Size, 2016-2027
6.4.5 Mexico Vaccine Conjugate Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Vaccine Conjugate Revenue, 2016-2027
6.5.2 By Country - Europe Vaccine Conjugate Sales, 2016-2027
6.5.3 Germany Vaccine Conjugate Market Size, 2016-2027
6.5.4 France Vaccine Conjugate Market Size, 2016-2027
6.5.5 U.K. Vaccine Conjugate Market Size, 2016-2027
6.5.6 Italy Vaccine Conjugate Market Size, 2016-2027
6.5.7 Russia Vaccine Conjugate Market Size, 2016-2027
6.5.8 Nordic Countries Vaccine Conjugate Market Size, 2016-2027
6.5.9 Benelux Vaccine Conjugate Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Vaccine Conjugate Revenue, 2016-2027
6.6.2 By Region - Asia Vaccine Conjugate Sales, 2016-2027
6.6.3 China Vaccine Conjugate Market Size, 2016-2027
6.6.4 Japan Vaccine Conjugate Market Size, 2016-2027
6.6.5 South Korea Vaccine Conjugate Market Size, 2016-2027
6.6.6 Southeast Asia Vaccine Conjugate Market Size, 2016-2027
6.6.7 India Vaccine Conjugate Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Vaccine Conjugate Revenue, 2016-2027
6.7.2 By Country - South America Vaccine Conjugate Sales, 2016-2027
6.7.3 Brazil Vaccine Conjugate Market Size, 2016-2027
6.7.4 Argentina Vaccine Conjugate Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccine Conjugate Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Vaccine Conjugate Sales, 2016-2027
6.8.3 Turkey Vaccine Conjugate Market Size, 2016-2027
6.8.4 Israel Vaccine Conjugate Market Size, 2016-2027
6.8.5 Saudi Arabia Vaccine Conjugate Market Size, 2016-2027
6.8.6 UAE Vaccine Conjugate Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Vaccine Conjugate Major Product Offerings
7.1.4 Pfizer Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Vaccine Conjugate Major Product Offerings
7.2.4 GSK Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Vaccine Conjugate Major Product Offerings
7.3.4 Sanofi Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Vaccine Conjugate Major Product Offerings
7.4.4 Merck Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Corporate Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Vaccine Conjugate Major Product Offerings
7.5.4 Walvax Biotechnology Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.5.5 Walvax Biotechnology Key News
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Major Product Offerings
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News
7.7 Bharat Biotech
7.7.1 Bharat Biotech Corporate Summary
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Vaccine Conjugate Major Product Offerings
7.4.4 Bharat Biotech Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.7.5 Bharat Biotech Key News
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Corporate Summary
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Vaccine Conjugate Major Product Offerings
7.8.4 Zhifei Biologic Vaccine Conjugate Sales and Revenue in Global (2016-2021)
7.8.5 Zhifei Biologic Key News
8 Global Vaccine Conjugate Production Capacity, Analysis
8.1 Global Vaccine Conjugate Production Capacity, 2016-2027
8.2 Vaccine Conjugate Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine Conjugate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine Conjugate Supply Chain Analysis
10.1 Vaccine Conjugate Industry Value Chain
10.2 Vaccine Conjugate Upstream Market
10.3 Vaccine Conjugate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine Conjugate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Vaccine Conjugate in Global Market
Table 2. Top Vaccine Conjugate Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Vaccine Conjugate Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Vaccine Conjugate Revenue Share by Companies, 2016-2021
Table 5. Global Vaccine Conjugate Sales by Companies, (K Doses), 2016-2021
Table 6. Global Vaccine Conjugate Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Vaccine Conjugate Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Vaccine Conjugate Product Type
Table 9. List of Global Tier 1 Vaccine Conjugate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic